[1] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[2] |
YANG Shipeng , LIU Ying , WANG Xinyue , YANG Yang , QUAN Jishu , LIN Zhenhua .
Clinical significance of PKLR overexpression in the pancreatic cancer
[J]. China Oncology, 2021, 31(8): 704-713.
|
[3] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[4] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[5] |
JIN Youping, LI Luying, ZHOU Ping.
A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(7): 596-604.
|
[6] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|
[7] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[8] |
GONG Runze, HU Haiyan.
Clinical significance of CCL2 expression in osteosarcoma tissue
[J]. China Oncology, 2021, 31(6): 455-459.
|
[9] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[10] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[11] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[12] |
ZHU Junjun, GE Naijian, YANG Yefa.
Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor
[J]. China Oncology, 2021, 31(4): 257-262.
|
[13] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[14] |
QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning .
Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells
[J]. China Oncology, 2021, 31(4): 277-284.
|
[15] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|